Efalizumab

Efalizumab (Raptiva, Genentech) is a medication used to treat psoriasis, juvenile rheumatoid arthritis, psoriasis, psoriatic arthritis, rheumatoid arthritis. It is a recombinant humanized monoclonal antibody that binds to CD11a and acts as an immunosuppressant. It is administered once weekly by subcutaneous injection.

It acts to inhibit white blood cell migration out of blood vessels into tissues.

Efalizumab Efalizumab